Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients

Oncology Reports

Volumn 32, Issue 6, 2014, Pages 2517-2526

  Xie, Deyao ^a   Lan, Linhua ^b,c   Huang, Kate ^a   Chen, Lin ^b,c   Xu, Cuicui ^b,c   Wang, Rongrong ^a   Shi, Yang ^b,c   Wu, Xiaoyi ^b,c   Wang, Lu ^b,c   Liu, Yongzhang ^b,c   Lu, Bin ^b,c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

^c School of Laboratory Medicine and Life Sciences   (China)

Author keywords

Immunohistochemistry; Non small cell lung cancer; P21; P53; Prognosis; Western blotting

Indexed keywords

PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TP53 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOBLOTTING; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL RATE; UPREGULATION; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE COURSE; KAPLAN MEIER METHOD; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SECONDARY;

CARCINOMA, NON-SMALL-CELL LUNG; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84914709061     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3538     Document Type: Article

References (26)

1. An Q, Liu Y, Gao Y, et al: Deletion of tumor suppressor genes in Chinese non-small cell lung cancer. Cancer Lett 184: 189-195, 2002.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Liu X, Lin XJ, Wang CP, Yan KK, Zhao LY, An WX and Liu XD: Association between smoking and p53 mutation in lung cancer: a meta-analysis. Clin Oncol (R Coll Radiol) 26: 18-24, 2014.
5. Tsou JA, Hagen JA, Carpenter CL and Laird-Offringa IA: DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21: 5450-5461, 2002.
6. Wang X, Christiani DC, Wiencke JK, et al: Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers Prev 4 543-548, 1995
7. Hwang SJ, Cheng LS, Lozano G, Amos CI, Gu X and Strong LC: Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet 113: 238-243, 2003.
8. Zhang H and Cai B: The impact of tobacco on lung health in China. Respirology 8: 17-21, 2003.
9. Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, Akie K and Kawakami Y: Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 76: 2457-2463, 1995.
10. Furrukh M: Tobacco smoking and lung cancer: perception-changing facts. Sultan Qaboos Univ Med J 13: 345-358, 2013.
11. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS and Hainaut P: Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21: 7435-7451, 2002.
12. Levine AJ, Momand J and Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991.
13. Yi C, Wang Q, Wang L, et al: MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31: 4421-4433, 2012.
14. Giono LE and Manfredi JJ: The p53 tumor suppressor participates in multiple cell cycle checkpoints. J Cell Physiol 209: 13-20, 2006.
15. Abbas T and Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414, 2009.
16. Waga S, Hannon GJ, Beach D and Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.
17. Zhang MF, Zhang ZY, Fu J, Yang YF and Yun JP: Correlation between expression of p53, p21/WAF1, and MDM2 proteins and their prognostic significance in primary hepatocellular carcinoma. J Transl Med 7: e110, 2009.
18. Hayashi H, Miyamoto H, Ito T, Kameda Y, Nakamura N, Kubota Y and Kitamura H: Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma. Am J Pathol 151: 461-470, 1997.
19. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohisto-chemical estrogen receptor detection (eR-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987 (In german).
20. Cheng AN, Jiang SS, Fan CC, et al: Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents. Cancer Lett 337: 218-225, 2013.
21. Hainaut P and Hollstein M: p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 77: 81-137, 2000.
22. Hollstein M, Moeckel G, Hergenhahn M, et al: On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res 405: 145-154, 1998.
23. Lakin N and Jackson S: Regulation of p53 in response to DNA damage. Oncogene 18: 7644-7655, 1999.
24. Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, Abbaszadegan MR and Malekzadeh R: Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol 16: 4958-4967, 2010.
25. Cruz I, Snijders PJ, Van Houten V, Vosjan M, Van der Waal I and Meijer CJ: Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas. J Clin Pathol 55: 834-840, 2002.
26. Mizobuchi S, Furihata M, Sonobe H, et al: Association between p53 immunostaining and cigarette smoking in squamous cell carcinoma of the esophagus. Jpn J Clin Oncol 30: 423-428, 2000.